If you purchase this report now and we update it in next 100 days, get it free!
Conduction vaporizers heat dried herbs, concentrates or other materials by direct contact with a hot surface, typically a ceramic, quartz, glass or metal chamber, so that active compounds turn into vapour without burning the material. They differ from convection vaporizers, which pass hot air through the material, and from combustion devices such as pipes and cigarettes. The category includes portable pen-style and compact herb vaporizers, dab pens and wax pens for concentrates, cartridge-based devices and desktop units, with features such as temperature control, rapid heating, rechargeable batteries and smartphone connectivity. Uses include legal adult-use and medical cannabis, aromatherapy and herbal products, and in some cases tobacco or nicotine-free botanicals, depending on local rules. Participants include PAX Labs, Storz and Bickel, Puffco, Yocan, Kandypens, Boundless Technology, Healthy Rips, DaVinci, Ispire, Smoore, KIND Tech, Dr. Dabber, G Pen (Grenco Science), Stundenglass and numerous smaller brands and contract manufacturers, particularly in Shenzhen. Success depends on heating quality, safety, regulatory compliance and brand trust. Many brands depend on contract manufacturers for batteries and heating elements and compete through design and testing.
The market has grown with legalisation of cannabis in many jurisdictions and a gradual move away from smoking toward vaporisation, but it remains fragmented and heavily regulated. Canada legalised adult-use cannabis in October 2018 and permitted vaporisers and concentrates from late 2019, Germany permitted private cultivation and possession for adults from April 2024, and the United States has a patchwork of state laws while federal rescheduling has been debated, with a proposal to move cannabis to a less restrictive schedule published in May 2024. At the same time, public health concerns about vaping-related lung injury in 2019, flavoured product bans, age limits and rules on batteries, heavy metals and counterfeit cartridges influence design and marketing. Through 2031, the market will depend on legalisation, product safety testing, battery regulation, consumer preference for ceramic and quartz heating elements, price competition from low-cost devices and the shift to connected, premium and discreet designs. Companies with compliance capabilities and quality manufacturing should be best placed. Retail access and advertising limits further shape how brands reach consumers.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Drivers •Legalisation of Cannabis and Preference for Vaporisation Over Smoking Legal medical and adult-use cannabis in Canada, many United States states, Germany and other countries is widening the number of customers, and consumers who want less smoke and odour often choose vaporisers. Vaporisation at controlled temperatures reduces combustion by-products and preserves flavour and terpenes, which appeals to both patients and recreational users. Dispensaries, medical programmes and online accessory shops provide trusted routes to purchase, and the wide range of price points widens adoption.
•Technology Improvement in Heating, Batteries and Connectivity Advances in ceramic, quartz and medical-grade materials, precise temperature control, fast heat-up and long-lasting lithium batteries are improving taste and efficiency, and compact design makes devices discreet and portable. Mobile apps allow users to set heating profiles and track usage, and some devices have haptic feedback and automatic shutoff. Better coil and chamber designs reduce wasted material and offer improved flavour, so users who try conduction products often upgrade to premium models.
Challenges •Regulatory Fragmentation, Federal Restrictions and Compliance Cost Rules differ greatly between countries and even between states and provinces, covering product registration, flavours, packaging, advertising, age limits and where vaporisers may be sold. In the United States cannabis remains illegal under federal law, which limits banking, advertising and interstate trade, and devices may fall under tobacco or drug paraphernalia rules depending on use. Compliance with testing, labelling and battery safety standards adds cost, and unlicensed or counterfeit products are common in illicit markets.
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Raj Shrivastav
Research Analyst
•Health and Safety Concerns, Product Quality and Price Competition The 2019 outbreak of vaping-associated lung injury, linked mainly to illicit cartridges containing vitamin E acetate, damaged public trust and led to stricter controls. Concerns include metal leaching from coils, battery fires, additives and inconsistent dosing. Low-cost devices from Asian manufacturers pressure prices and quality, and many brands face limited access to mainstream marketing channels, so differentiation through verified safety, lab results and warranty is difficult but important. Retail access is limited.
Trends •Premium, Smart and Concentrate-Focused Devices Higher-end conduction and hybrid devices with app control, precise temperature steps, travel-friendly designs and long battery life are gaining ground. Concentrate vaporisers, including dab pens and electronic rigs, are expanding quickly as consumers adopt live resin and rosin products. Brands emphasise ceramic or quartz heating, borosilicate glass and stainless steel to deliver clean taste, and use limited editions, collaborations and design to build loyalty among experienced users. Sales are growing steadily.
•Safety Testing, Sustainability and Hardware Standards Manufacturers publish certificates for heavy metals and materials, adopt child-resistant and tamper-evident packaging, and use certified batteries. Repairable and refillable designs, recyclable cartridges and take-back programmes are being introduced in response to rules on electronic and battery waste. Standardised cartridge connections such as 510-thread and pod systems help interoperability, and compliance with electrical and radio standards such as CE and FCC marks supports sales across several countries. Third-party testing is becoming common.
Don't pay for what you don't need. Save 30%
Customise your report by selecting specific countries or regions
Portable herb vaporizers lead because they combine discreet use, temperature control and flavour for dry cannabis and herbs, while concentrate and dab pens grow fastest with rising use of extracts and rosin products. Portable herb vaporizers are the largest product type because they allow dried cannabis flower or herbs to be heated at precise temperatures in a compact, rechargeable device, with strong demand from medical patients and regular consumers who favour full-spectrum flavour. Conduction designs heat quickly and are simple, inexpensive and easy to use, though they can heat unevenly compared with convection systems. Concentrate and dab pens use ceramic or quartz heating elements to vaporise oils, wax, shatter and rosin, and are the fastest growing group as concentrates become widely available in legal markets and users look for convenience and strong effects. Cartridge and pod devices use pre-filled oil cartridges attached to a battery, with simple draw activation, and are popular for convenience and discretion, but face the greatest regulatory and counterfeit challenges. Desktop vaporizers, often premium units for home use, provide precise control, large capacity and shared sessions, and are favoured by medical and enthusiast users. Through 2031, concentrate devices and premium portable units are expected to grow fastest, while cartridge systems remain important in markets with strong regulated oil sales, and design differentiation, battery life and heat quality are key competitive factors.
Ceramic heating elements lead because they heat evenly, taste clean and last well in both herb and concentrate devices, while quartz grows fastest through premium concentrate use and purity-focused buyers. Ceramic heating elements are the largest group because ceramic heats evenly, is inert, avoids metallic taste, and is used in both herb chambers and concentrate coils in a wide range of price points. It is durable, cleans easily and suits mass production, which supports both mainstream and premium brands. Quartz elements, usually quartz crystal or quartz coils and bangers, are the fastest growing because users of concentrates value clean flavour, quick heating and high purity, and quartz resists thermal shock and does not release metals, although it is brittle and more expensive. Stainless steel and metal elements are strong, inexpensive and common in basic herb vaporizers and low-cost pens, but can affect taste and raise concerns about metal leaching if the grade or coating is poor, so higher-grade medical steel and tested alloys are preferred. Glass and other materials, including borosilicate mouthpieces and glass chambers, are used for vapour paths and some heating zones, giving purity of taste and easy cleaning, and are popular with enthusiasts. Through 2031, quartz and high-quality ceramic are expected to gain share as buyers emphasise safety, taste and independent testing, while metal elements remain in entry-level products.
Recreational adult-use cannabis leads because legal retail markets are growing and consumers want smoke-free options, while medical cannabis grows steadily as clinicians and patients seek controlled dosing in regulated markets. Recreational adult-use cannabis is the largest application because legal retail markets in Canada, many United States states and some European countries have widened access, and consumers who previously smoked now choose vaporisers for discretion, taste and lower odour. Brand and lifestyle marketing within permitted limits builds loyalty, and accessories are commonly sold through dispensaries and specialist shops. Medical cannabis is a stable and growing application because patients and clinicians value controlled temperature and dosing, and several countries, including Germany, Australia and parts of Europe, allow prescription of dried flower for vaporisation, so medical-grade devices with consistent heating and quality certification are in demand. Herbal and aromatherapy use includes vaporisation of herbs, essential oils and other botanicals for relaxation and wellness, and is popular among consumers seeking alternatives to combustion where legal. Other botanical and wellness use includes research, nicotine-free botanical products and personal care devices, with smaller volumes but potential for premium design. Through 2031, medical and new legal adult-use markets, such as Germany, are expected to add growth, while established markets in North America are expected to mature, with competition and price pressure moving buyers toward value and premium tiers.
Dispensaries and specialty vape shops lead because they provide trusted access, advice and compliant products, while online retail and brand websites grow fastest where laws allow shipping and consumers want choice. Dispensaries and specialty vape shops are the largest channel because they sell licensed cannabis products and compatible devices, provide staff advice and demonstrations, and give buyers confidence in compliance and quality. They are particularly important in North America, where legal retail is licensed, and brands often work with dispensaries on promotions. Online retail and brand websites are the fastest growing channel where regulations allow, because shoppers can compare features, read reviews, view heating tests and buy premium or hard-to-find products, though payment, age verification and shipping rules create difficulties, and some marketplaces restrict sales. Head shops and convenience stores sell lower-cost devices and accessories to adult consumers, and benefit from impulse sales and wide geographic reach, but face tightening rules in some jurisdictions. Pharmacies and medical suppliers are important in countries with prescription cannabis programmes, such as Germany, Australia and parts of Europe, where certified medical devices are dispensed with professional guidance. Through 2031, online and pharmacy channels are expected to expand with legalisation and telehealth prescribing, while dispensaries remain central in adult-use markets, and brands will invest in education, warranties and service to differentiate their products. Compliance with local licensing and age checks remains essential.
North America leads conduction vaporizers through legal cannabis retail, strong brands and consumer demand for premium devices, while Europe grows through medical programmes and new legalisation, Asia-Pacific supplies manufacturing, and other regions remain limited by regulation. North America is the largest region because of legal cannabis markets in Canada and many United States states, an established network of dispensaries and a large base of experienced consumers. The United States is a patchwork, with state-licensed retail alongside federal prohibition, and a proposal in May 2024 to move cannabis to a less restrictive federal schedule has kept attention on possible changes in banking, taxes and research. The Food and Drug Administration regulates vaping devices for tobacco under its authority, and state rules on flavours, age limits, testing and battery standards influence cannabis device design. Brands such as PAX, Puffco, Storz and Bickel, G Pen, Dr. Dabber and KandyPens compete in a market that has also seen consolidation and price competition. Canada legalised adult-use cannabis in October 2018 and allowed vaporisers and extracts from late 2019, with regulation of devices, packaging and potency, while Mexico moved toward legal use after a court ruling and is still developing its regulatory framework. The 2019 lung injury outbreak raised safety concerns. By 2031, growth is expected from premium devices, concentrates and any federal reform. Retail consolidation and licensing costs also shape supplier strategies.
Europe is a developing region in which medical cannabis programmes and gradual legalisation are expanding the use of vaporisers, while tobacco and vaping rules strongly shape the retail environment. Germany is the key market, with medical cannabis established and private cultivation and possession for adults permitted from April 2024, which increased interest in herb vaporisers. The Netherlands, Switzerland, Czechia, Malta and Luxembourg have pilots or reforms, and several other countries are considering changes. Storz and Bickel, a German maker of medical-grade vaporisers, is among the most recognised European brands, and devices are often sold as medical products with certification. The United Kingdom has a medical cannabis system and has banned disposable vapes from June 2025, which affects the overall vaping category and increases scrutiny of battery products. The Tobacco Products Directive and national laws regulate nicotine vaping, and cannabis devices must be placed on the market under general product safety and electrical regulations. Consumer awareness of health and sustainable batteries is growing. By 2031, growth is expected from medical use, new legal frameworks and demand for premium, repairable devices. Pharmacy supply and certification requirements will influence which brands succeed.
Asia-Pacific is the main manufacturing base for conduction vaporizers, with China, particularly Shenzhen, producing a large share of the world's vaporizer hardware, batteries and ceramic coils for global brands. Companies such as Smoore and Ispire supply components and finished products, and the region's engineering and supply chains support rapid innovation and low cost. Domestic consumption is limited because cannabis is illegal in most countries, and China, Japan, South Korea and Singapore apply strict penalties, although cannabis-derived non-psychoactive products and hemp-based goods are produced in some places. Thailand decriminalised cannabis in 2022 and developed a medical and wellness market, which has encouraged some local demand for devices and tourism-linked sales, but rules have been under review. Australia has a medical cannabis programme under which prescribed dried flower may be vaporised, and New Zealand has a medicinal cannabis scheme. Regulators concerned about vaping have restricted e-cigarettes in many countries, which also affects perceptions and trade. By 2031, the region is expected to remain the main supplier of devices and components, with local demand growth in Australia and any countries that relax cannabis laws. Manufacturing quality standards continue to rise under export buyer requirements.
Latin America is an emerging region where legal cannabis frameworks are evolving and vaporizer use is concentrated in medical and tolerant jurisdictions. Uruguay was the first country to legalise adult-use cannabis in 2013 and has a regulated system with pharmacies and clubs, although device markets are small. Colombia has a large medical cannabis industry and is an exporter of cannabis extracts, and its regulation supports medical programmes. Brazil permits some medical cannabis products through the national health surveillance agency, ANVISA, and debates on broader rules continue, while the importation and sale of vaporisers have been restricted for tobacco-type electronic devices. Mexico's supreme court rulings have opened the way to personal use, but a full regulated market has not yet been established. Argentina and Chile have medical frameworks and growing patient communities. Barriers include regulatory uncertainty, import duties, limited access to specialised retail, price sensitivity and illicit products. Many devices are imported from Asia and North America through distributors and online sellers. By 2031, growth is expected from medical cannabis programmes and any reforms in Mexico and Brazil, with a small but growing premium device segment.
The Middle East and Africa are the most restricted regions for conduction vaporizers, because cannabis is illegal in most countries and strict penalties apply, so the market is small and mainly limited to specific jurisdictions. South Africa is the most significant, as its constitutional court decriminalised private use and cultivation by adults in 2018 and the Cannabis for Private Purposes Act was signed in 2024, which supports a growing grey market for accessories and vaporisers. Lesotho and Zimbabwe have licensed cannabis production for medical and export uses, and Malawi, Uganda, Rwanda and Ghana have introduced or considered licensing for industrial or medical cannabis. Israel has a mature medical cannabis system and research sector, with vaporisers commonly prescribed, and exports of cannabis products. Elsewhere in the Middle East, including the Gulf, cannabis remains strictly prohibited, though herbal and aromatherapy devices have limited sale. Barriers include law enforcement risk, limited retail access and low purchasing power. Imports from Asia and Europe supply most hardware. By 2031, growth is expected only in a few markets such as South Africa and Israel, and in medical and export-focused programmes in selected African countries.
June 2025 – UK bans disposable vapes: The prohibition on single-use vaporisers took effect on 1 June 2025, raising attention on battery waste and encouraging rechargeable, refillable device designs.
May 2024 – US proposes moving cannabis to a less restrictive federal schedule: The proposed rule would shift cannabis to Schedule III, which could change tax, research and commercial conditions if finalised.
April 2024 – Germany allows private cannabis cultivation and possession for adults: The law took effect on 1 April 2024 and widened potential demand for herb vaporisers in Europe's largest economy.
February 2020 – CDC reports final tally for vaping-associated lung injury outbreak: The agency recorded 2,807 hospitalised cases and 68 deaths, linking many to vitamin E acetate in illicit cartridges, which led to stricter product controls.
December 2019 – Canada begins sales of cannabis vaporisers and extracts: The second phase of the Cannabis Act allowed legal sale of vape products and concentrates, expanding the regulated device market.
Considered in this report
• Historic Year: 2020
• Base Year: 2025
• Estimated Year: 2026
• Forecast Year: 2031
Aspects covered in this report
• Global Conduction Vaporizers Market with its segments and regional outlook
• Various drivers and challenges
• Ongoing trends and developments
• Key developments and regulatory milestones
By Product Type
• •Portable herb vaporizers
• •Concentrate and dab pens
• •Cartridge and pod devices
• •Desktop vaporizers
By Heating Element Material
• •Ceramic
• •Quartz
• •Stainless steel and metal
• •Glass and other materials
By Application
• •Recreational (adult-use) cannabis
• •Medical cannabis
• •Herbal and aromatherapy
• •Other botanical and wellness use
By Distribution Channel
• •Dispensaries and specialty vape shops
• •Online retail and brand websites
• •Head shops and convenience stores
• •Pharmacies and medical suppliers
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information